Saturday 17 October 2026 Export TXG’s income statement to Excel — free account

10x Genomics

TXG Healthcare Health Information Services

10x Genomics' revenue for fiscal 2025 (year ended December 2025) was $642.8 million, up 5.25% from fiscal 2024. In the quarter to June 2026, revenue fell 12.7%, EPS fell 150.0% and free cash flow fell 4.61%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

69.86 2.53 −3.49%

Follow TXG

Alert me

Market cap: $9.4B
P/E: 0.0×
Fwd P/E: −38.1×
Dividend yield: —
F-score: 6/9
Altman Z: 3.99
Beneish M: −3.23
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	8.08	4.26	3.17	2.29
P/FCF ratio Full definition →	41.38	22.48	15.76	18.19
P/Operating CF Full definition →	293.60	104.27	49.90	33.95
P/B ratio Full definition →	6.04	3.34	2.56	1.87
Price to Tangible BV Full definition →	6.58	3.63	2.79	2.05
EV/Sales Full definition →	7.23	3.47	2.40	1.58
EV/EBITDA Full definition →	0.00	314.06	0.00	0.00
EV/Operating CF Full definition →	35.10	17.32	11.33	11.46
EV/FCF Full definition →	37.04	18.27	11.93	12.58
Quick Ratio Full definition →	5.09	5.25	3.95	3.93
Current Ratio Full definition →	5.69	5.90	4.46	4.48
Net Debt/EBITDA Full definition →	93.22	76.15	63.41	25.14
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.61	0.67	0.66	0.65
Operating CF/Net income Full definition →	(0.95)	(1.94)	(2.51)	(1.57)
Capex/Depreciation Full definition →	(0.12)	(0.16)	(0.16)	(0.05)
Interest Coverage Full definition →	—	—	—	10,747.33
Research and Development Expense of Revenue Full definition →	37.60%	37.69%	33.71%	38.38%
Selling, General and Administrative Expense of Revenue Full definition →	52.08%	44.00%	46.15%	50.57%
Intangible Assets out of Total Assets Full definition →	0.07	0.06	0.06	0.07
Share Based Compensation of Revenue Full definition →	16.96%	15.01%	15.19%	16.96%
Graham Net Nets Full definition →	0.09	0.17	0.22	0.28
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(1.54%)	(0.80%)	(2.15%)	(5.30%)
Free Cash Flow Yield Full definition →	2.42%	4.45%	6.35%	5.50%
Revenue per Share Full definition →	1.16	1.18	1.33	1.19
Operating CF per Share Full definition →	0.13	0.20	0.33	0.34
Capex per Share Full definition →	(0.01)	(0.01)	(0.01)	(0.01)
Free Cash Flow per Share Full definition →	0.12	0.19	0.31	0.34
Cash per Share Full definition →	4.25	4.21	4.20	3.84
Shareholders Equity per Share Full definition →	6.35	6.35	6.38	6.26
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	6.35	6.35	6.38	6.26
Free Cash Flow Full definition →	15.39	24.52	39.00	42.53
Working Capital Full definition →	556.16	556.14	531.00	512.50
Capital Expenditures Full definition →	(1.59)	(1.60)	(1.78)	(0.69)
Net Current Asset Value Full definition →	470.15	468.30	439.41	417.59
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.01	0.01	0.01	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	84.85	54.34	85.48	90.06
Average Payables Full definition →	18.32	13.75	12.82	22.14
Average Inventory Full definition →	60.79	64.10	69.72	78.00
Average Assets Full definition →	1,005.02	959.58	980.00	982.58
Average Common Equity Full definition →	799.41	760.61	753.23	753.96

Show all line items

Columns are period end dates

Stockrow Weekly